articleTop 1% cited
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Psychopharmacology · 2011 · Vol. 218(4) · pp. 649–665
Roland R. Griffiths✉(Johns Hopkins Medicine)Matthew W. Johnson(Johns Hopkins Medicine)William A. Richards(Johns Hopkins University)Brian D. Richards(Johns Hopkins Bayview Medical Center)Una D. McCann(Johns Hopkins Medicine)Robert L. Jesse
Psychedelics and Drug StudiesChemical synthesis and alkaloidsCannabis and Cannabinoid ResearchPsilocybinMoodPsychologyPlaceboHallucinogenAnxietyProfile of mood statesMedicineClinical psychologyPsychiatry
MeSH terms
AdultAffectAttitudeDose-Response Relationship, DrugDouble-Blind MethodFemaleFollow-Up StudiesHallucinogensHumansMaleMiddle AgedPsilocybinSurveys and QuestionnairesTime FactorsCross-Over Studies
Funding
- National Institutes of Health
Citations
918
FWCI
19.49
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
Cited by
Predicting Responses to Psychedelics: A Prospective Study
Frontiers in Pharmacology · 2018 · 411 citations
Psychedelics Promote Structural and Functional Neural Plasticity
Cell Reports · 2018 · 1,094 citations
References
Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man
Clinical Pharmacology & Therapeutics · 1971 · 958 citations
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Life Sciences · 1984 · 632 citations
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Psychopharmacology · 2006 · 1,644 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.